These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Chlamydia screening criteria must go beyond sex partners, OC use.
    Journal: Contracept Technol Update; 1988 Apr; 9(4):41-4. PubMed ID: 12281081.
    Abstract:
    Broad-scale chlamydia testing of family planning clinic populations has been advocated by public health organizations such as the Centers for Disease Control, but the criteria for such screening remain controversial. The Family Planning Council of Central Pennsylvania found the following criteria to be predictive for chlamydial infection: age under 25 years, abnormal discharge, mucopurulent exudate, and cervical ectropion. The commonly accepted risk factors of number of sexual partners, oral contraceptive use, and gonococcal infection were not significant predictors of chlamydia. A large chlamydia screening project underway in Family Planning Region X (Alaska, Oregon, Idaho, and Washington) plans to screen any patient who exhibits 2 or more of the following criteria: age under 24 years, sexually active, has multiple sex partners, has a new sex partner, has a sex partner with multiple sex partners, or uses a nonbarrier method of birth control. California researchers have devised a cost analysis to determine whether the expense of testing all patients in state-supported family planning programs for chlamydia would be offset by the cost savings involved in avoiding hospitalization and treatment of infected women suffering sequelae such as pelvic inflammatory disease. Preliminary calculations indicate that, in populations with an infection prevalence of 2% or more (most family planning clinics have a chlamydia prevalence rate of 7-10%), such screening will pay for itself. The researchers believe that a state-wide screening program in California would eliminate 33,516 chlamydia infections/year, preventing 8379 cases of pelvic inflammatory disease, 1005 surgical procedures related to that disease, 335 ectopic pregnancies, and 1760 cases of tubal infertility, for a net savings of over US$13 million.
    [Abstract] [Full Text] [Related] [New Search]